Symbol="STOK"
AssetType="Common Stock"
Name="Stoke Therapeutics Inc"
Description="Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops new antisense oligonucleotide (ASO) drugs to treat the underlying causes of serious genetic diseases in the United States. The company is headquartered in Bedford, Massachusetts."
CIK="1623526"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="3 PRESTON COURT, BEDFORD, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="446304000"
EBITDA="-102355000"
PERatio="None"
PEGRatio="None"
BookValue="4.84"
DividendPerShare="0"
DividendYield="0"
EPS="-2.25"
RevenuePerShareTTM="0.362"
ProfitMargin="0"
OperatingMarginTTM="-7.16"
ReturnOnAssetsTTM="-0.218"
ReturnOnEquityTTM="-0.436"
RevenueTTM="14557000"
GrossProfitTTM="12405000"
DilutedEPSTTM="-2.25"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.717"
AnalystTargetPrice="25.56"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="35.82"
PriceToBookRatio="1.619"
EVToRevenue="8.87"
EVToEBITDA="-0.807"
Beta="0.368"
num_52WeekHigh="22.87"
num_52WeekLow="6.88"
num_50DayMovingAverage="11.35"
num_200DayMovingAverage="10.19"
SharesOutstanding="44188500"
DividendDate="None"
ExDividendDate="None"
symbol="STOK"
open="10.02"
high="10.33"
low="10.00"
price="10.10"
volume="134192.00"
latest_trading_day="2023-07-07"
previous_close="10.02"
change="0.08"
change_percent="0.7984%"
aroon_positive_momentum_days="74"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="74"
Volume_recent_avg="249531"
Change_recent_avg="0.01"
Delta_recent_avg="0.64"
Variance_recent_avg="0.32"
Change_ratio_recent_avg="-0.03"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="74"
Aroon_momentum_negative="26"
image_negative_thumbnail_id_1="165"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0011.jpeg"
image_negative_thumbnail_id_2="121"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0055.jpeg"
image_neutral_thumbnail_id_1="556"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0043.jpeg"
image_neutral_thumbnail_id_2="583"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0016.jpeg"
image_positive_thumbnail_id_1="991"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0153.jpeg"
image_positive_thumbnail_id_2="962"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0124.jpeg"
image_professor_thumbnail_id_1="1178"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0012.jpeg"
image_professor_thumbnail_id_2="1190"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
